Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
379 News Items found
Pancreatic tumor cells
In the Lab
Studying a Forerunner of Pancreatic Cancer Reveals New Clues about How the Disease Develops

This research is important for developing better drugs and screening methods for pancreatic tumors.
Sloan Kettering Institute molecular biologist Christine Mayr
In the Lab
Scientists Find Cancer Drivers Hiding in a New Place

New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
In the Lab
MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors

The engineered immune cells secrete powerful drugs as a layer of defense.
Five people on the beach during a sunset
Ask the Expert
Does Vitamin D Reduce the Risk of Getting Cancer?

Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello
Announcement
FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
In the Lab
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.
CT scans of brains
Finding
Research Advances the Genetic Understanding of Pineoblastoma, a Rare Brain Cancer

The findings will lead to more accurate diagnoses and, potentially, to better treatments.
MSK computational biologist Barry Taylor
Finding
Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.
MSK physician-scientist Omar Abdel-Wahab
In the Lab
Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.
Side-by-side images of brain MRIs.
Feature
New Imaging Technique Provides Snapshot of Brain Tumor Activity

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.